Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127606301 | 12760630 | 1 | I | 20160905 | 20160919 | 20160919 | EXP | IE-TEVA-693035ISR | TEVA | STORAN ER, O^GORMAN SM, MARKHAM T. GENERALIZED PUSTULAR PSORIASIS TREATED WITH USTEKINUMAB. CLIN-EXP-DERMATOL 2016;41(6):689-690. | 90.00 | YR | F | Y | 0.00000 | 20160920 | OT | IE | IE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127606301 | 12760630 | 1 | PS | ACITRETIN. | ACITRETIN | 1 | Unknown | 91455 | 30 | MG | |||||||||
| 127606301 | 12760630 | 2 | SS | NEORAL | CYCLOSPORINE | 1 | Unknown | 0 | 2.5 | MG/KG | |||||||||
| 127606301 | 12760630 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | 2.5 | MG | /wk | ||||||||
| 127606301 | 12760630 | 4 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | 10 | MG | /wk | ||||||||
| 127606301 | 12760630 | 5 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | 20 | MG | /wk | ||||||||
| 127606301 | 12760630 | 6 | C | folinic acid | LEUCOVORIN | 1 | Unknown | U | 0 | ||||||||||
| 127606301 | 12760630 | 7 | C | adalimumab | ADALIMUMAB | 1 | Unknown | 0 | 40 | MG | /wk | ||||||||
| 127606301 | 12760630 | 8 | C | ustekinumab | USTEKINUMAB | 1 | Unknown | U | 0 | 45 | MG | ||||||||
| 127606301 | 12760630 | 9 | C | ustekinumab | USTEKINUMAB | 1 | U | 0 | |||||||||||
| 127606301 | 12760630 | 10 | C | ustekinumab | USTEKINUMAB | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127606301 | 12760630 | 1 | Pustular psoriasis |
| 127606301 | 12760630 | 2 | Pustular psoriasis |
| 127606301 | 12760630 | 3 | Pustular psoriasis |
| 127606301 | 12760630 | 4 | Pustular psoriasis |
| 127606301 | 12760630 | 5 | Pustular psoriasis |
| 127606301 | 12760630 | 7 | Pustular psoriasis |
| 127606301 | 12760630 | 8 | Pustular psoriasis |
| 127606301 | 12760630 | 9 | Pustular psoriasis |
| 127606301 | 12760630 | 10 | Pustular psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127606301 | 12760630 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127606301 | 12760630 | Acute kidney injury | |
| 127606301 | 12760630 | Hepatic function abnormal | |
| 127606301 | 12760630 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127606301 | 12760630 | 7 | 201102 | 0 | ||
| 127606301 | 12760630 | 8 | 201102 | 0 |